SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-003202
Filing Date
2022-01-11
Accepted
2022-01-11 16:35:48
Documents
2
Group Members
D-BETA ONE BLOCKER EQ, LTD.D-BETA ONE EQ, LTD.D-BETA ONE GP, LLCD-BETA ONE GROWTH & OPPORTUNITY FUND OFFSHORE, LP (98-1312519)MARK ANGELOSC-SIGMA GLOBAL PARTNERS, LPYA GLOBAL INVESTMENTS II (U.S.), LPYA II GP II, LLCYA II GP, LPYORKVILLE ADVISORS GLOBAL I

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm222640d3_sc13ga.htm SC 13G/A 183935
2 EXHIBIT 99.1 tm222640d3_ex99-1.htm EX-99.1 24084
  Complete submission text file 0001104659-22-003202.txt   210263
Mailing Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302
Business Address 101 HUDSON STREET #3700 JERSEY CITY NJ 07302 201 985 8300
YA II PN, Ltd. (Filed by) CIK: 0001463928 (see all company filings)

IRS No.: 980615492 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Subject) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-89881 | Film No.: 22524315
SIC: 2834 Pharmaceutical Preparations